🇺🇸 FDA
Patent

US 10119140

Methods for enhancing or decreasing the levels of MIR124 and MIR29 in subjects with muscular dystrophy

granted A61KA61K31/713A61K45/06

Quick answer

US patent 10119140 (Methods for enhancing or decreasing the levels of MIR124 and MIR29 in subjects with muscular dystrophy) held by BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO
Grant date
Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/713, A61K45/06, A61P, A61P21/00